News
Yuka is a health-focused app that uses AI to analyze the ingredients, additives and potential allergens in food and cosmetic ...
Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
The chemical is bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate, also called BTMPS, which is in a group of chemicals called ...
Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. | Rhythm Pharmaceuticals’ push to ...
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Reading food labels isn’t enough! THESE everyday ingredients are causing havoc on health; know why TOI Lifestyle Desk / etimes.in / Jun 28, 2025, 22:00 IST AA ...
Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has approved label updates for both of its CAR T cell therapies, Breyanzi (lisocabtagene maraleucel; liso-cel) for the ...
From root beer-flavored barbecue sauce to dill pickle-flavored cheese shreds, this week’s new product innovations span all sides of the industry. Check out the latest edition of the New Product ...
Restricted availability under an FDA-mandated drug safety program has limited the reach of CAR-T cell therapies for certain blood cancers—until now. | The FDA has removed the REMS requirements ...
We asked beauty editors and experts to share the products from The Ordinary they always restock.
What is private labeling? Private labeling allows brands to outsource product sourcing and manufacturing to a third party. With private labeling, you apply the brand to the packaging only when it is ...
Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results